Bill & Melinda Gates Foundation
-
NIH, Gates Foundation invest $200M to develop gene therapies for developing countries
The partnership will have a particular focus on therapies to treat sickle cell disease and HIV, with each party committing $100 million to the effort.
-
Vedanta Biosciences raises $27M in Series C round
The company plans to use the funding to support its various microbiome-based drug development programs in oncology, food allergy and bacterial infection.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Morning Read: Bill & Melinda Gates Foundation grants $9.6M to reduce newborn mortality in Ethiopia
The Institute for Healthcare Improvement announced that it received a $9.6M grant from the Bill & Melinda Gates Foundation to reduce newborn mortality in Ethiopia.
-
Kids’ immunization records redesigned are way more graphic, personalized & flexible
While healthcare providers in the U.S. struggle with design challenges of electronic medical record systems, […]
-
Colorado biotech’s latest milestones exemplify big-picture progress toward a dengue vaccine
The tropical disease dengue fever isn’t something we hear or worry about much in the […]
-
Investors add $30 million to infectious disease vaccine developer Genocea Biosciences
A vaccine developer focused on fighting infectious diseases like HSV-2, Pneumococcus and malaria has just […]
-
iBio seeks to raise $10 million for plant-based vaccine production
iBio (NYSE:IBIO) is seeking to raise $10 million for its plant-based vaccine production in a […]